BRIEF published on 05/23/2025 at 07:57, 1 year 3 months ago AB Science renforce sa trésorerie avec une augmentation de capital Euronext Paris Financement Augmentation De Capital Investisseurs AB Science
BRIEF published on 05/23/2025 at 07:57, 1 year 3 months ago AB Science strengthens its cash flow with a capital increase Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 3 months ago AB Science : AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse Augmentation De Capital Trésorerie AB Science Masitinib AB8939
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 3 months ago AB Science announces the settlement delivery of its latest capital increase for €1.8 million AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases Healthcare Industry Financial News Capital Increase Drug Development AB Science
BRIEF published on 05/20/2025 at 07:54, 1 year 3 months ago AB Science Completes EUR 1.8 Million Private Placement Private Placement Euronext Paris Share Warrants AB Science AB8939 Development
BRIEF published on 05/20/2025 at 07:54, 1 year 3 months ago AB Science finalise un placement privé de 1,8 million d'euros Euronext Paris Placement Privé Bons De Souscription D'actions AB Science Développement AB8939
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 3 months ago AB Science announces the successful completion of a EUR 1.8 million private placement AB Science successfully completes EUR 1.8 million private placement for clinical development. New shares issued with warrants attached for financing ongoing activities Private Placement Capital Increase Clinical Development Share Issuance AB Science
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 3 months ago AB Science annonce le succès d'un placement privé de 1,8 millions d'euros AB Science annonce le succès d’un placement privé d’environ 1,8 million d’euros pour financer le développement clinique du programme AB8939 Financement Placement Privé Développement Clinique AB Science AB8939
BRIEF published on 05/19/2025 at 07:56, 1 year 3 months ago AB Science obtient un brevet en Chine pour le masitinib contre la COVID-19 COVID-19 Antiviral AB Science Masitinib Brevet Chinois
BRIEF published on 05/19/2025 at 07:56, 1 year 3 months ago AB Science obtains a patent in China for masitinib against COVID-19 COVID-19 Antiviral AB Science Masitinib Chinese Patent
Published on 09/12/2026 at 02:35, 11 hours 49 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 24 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 19 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 59 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 24 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 54 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 16 hours 9 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 16 hours 14 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 40 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 20 hours 9 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
